|
Department of Urology
Clinical Trials
Clinical trials allow physicians and researchers to develop better and more effective
therapy for patients. Many of the standard treatments seen today were initially found to
be useful through clinical trials. Clinical trials also offer patients access to new
treatments that may be beneficial when standard treatments have failed. The Department of
Urology at the OU Medical Center is actively involved in Clinical Trials in hopes of
improving care for patients.
Prostate Cancer - Open to Enrollment
- CELL GENESYS - Title: A Phase III Randomized, Open-Label Study of CG1940 and CG8711
Versus Docetaxel and Estramustine in Patients with Metastatic Hormone-Refractory Prostate
Cancer who are Chemotherapy-Naïve.
- GTX - Title: G300203: A Randomized, Double-Blind, Placebo-Controlled, Multicenter
Efficacy and Safety Study of Toremifene Citrate for the Prevention of Bone Fractures in
Men with Prostate Cancer on Androgen Deprivation Therapy.
- SWOG, 9917 - L-Selenium-Based Chemoprevention of Prostate Cancer Among Men with High-Grade
Prostatic Intraepithelial Neoplasia.
- SWOG, 9921 - Adjuvant Androgen Deprivation versus Mitoxantrone Plus Prednisone Plus Androgen
Deprivation in Selected High Risk Prostate Cancer Patients Following Radical Prostatectomy.
- SWOG, 9346 - Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer, Phase III.
- BAYER, INC: “REINVENT” - A randomized double-blind, multi-center parallel group 14-month
study to compare the tolerability and efficacy of once daily Vardenafil versus Vardenafil PRN versus
placebo in men immediately after nerve -sparing prostatectomy for improving erectile function recovery.
- PIVOT - Prostate Cancer Intervention Versus Observation Trial. (Closed)
- SELECT - Selenium and Vitamin E Cancer Prevention Trial. (Closed)
Bladder Cancer - Open to Enrollment
- SWOG, 0219 - A Sequential Approach to the Treatment of Muscle Invasive,
Non-Metastatic Carcinoma of the Bladder: A Phase II Trial of Neoadjuvant Gemcitabine, Paclitaxel
and Carboplatin with Molecular Correlates.
- UCLA-Bladder Cancer Multicenter Study. Title: Parallel, Randomized, Double-Blind, Placebo
Controlled Phase II Adjuvant Studies of Erlotinib and Polyphenon E to Prevent the Recurrence and
Progression of Tobacco-Related, High-Grade Superficial Bladder Cancer. (Awaiting IRB Approval)
Penile Cancer - Open to Enrollment
- SWOG, 0224 - Phase II Study of Weekly Docetaxel in Patients with Advanced Epidermoid
Carcinoma of the Penis.
Overactive Bladder - Open to Enrollment
- PFIZER - Title: A Randomized, Double-Blind, Placebo Controlled, Four Arm
(Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study to Evaluate the
Clinical Efficacy and Safety of Tolterodine ER 4 MG in Men who have Frequency and Urgency, with
or without Urinary Urge Incontinence, with or without Bladder Outlet Obstruction.
Erectile Dysfunction - Open to Enrollment
- AMS 052: A Multicenter Study to Assess the AMS IPP 2005 Inflatable Penile
Prosthesis Cylinders, Pump, and Reservoir
Clinical Trials Office
If you are interested in more information regarding clinical trials offered by the Department of
Urology please contact one of our clinical trials coordinators.
Vickie Vanhooser, RN
vickie-vanhooser@ouhsc.edu
405 271 6900
Kris Rowland, RN
kris-rowland@ouhsc.edu
405 271 6900
Karen Mataranglo, RN
karen-mataranglo@ouhsc.edu
405 271 6900
|
